- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Bayer AG (BAYZF)
| Open: | 110.3500 | Day's Range: | 110.3500 - 110.7500 | Volume: | 350 |
|---|---|---|---|---|---|
| Previous Close: | 109.4000 | 52wk Range: | 60.0000 - 110.7500 | 1-Yr Rtn: | +71.98% |
Key Statistics for BAYZF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 14.7689 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (EUR) (ttm) | - |
| Est. EPS (EUR) (12/2013) | 5.8280 |
| Est. PEG Ratio | 1.4217 |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 414 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 2.27% |
| Cash Dividend (EUR) | 1.9000 |
| Last Dividend | 04/29/2013 |
| 5 Year Dividend Growth | 3.32% |
| Next Earnings Announcement | 07/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BAYZF
Company Profile & Key Executives for BAYZF
Bayer AG produces and markets healthcare and agricultural products, and polymers. The Company manufactures products that include aspirin, antibiotics, anti-infectives, and cardiovascular, oncology, and central nervous system drugs, over-the-counter medications, diagnostics, animal health products, crop protection products, plastics, and polyurethanes.
| Marijn E DekkersChairman-Mgmt Board/CEO | Werner BaumannCFO/Member-Mgmt Board |
| Wolfgang PlischkeCTO/Member-Mgmt Board | Richard PottChief Strategy & Human Resource |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BAYZF News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page